2021, Number 4
<< Back Next >>
Revista Cubana de Cirugía 2021; 60 (4)
Extended transsternal thymectomy in patients with myasthenia gravis
Fuentes VE, Pérez GK
Language: Spanish
References: 16
Page: 1-12
PDF size: 428.24 Kb.
ABSTRACT
Introduction:
Acquired myasthenia gravis (MG) is a neuromuscular transmission disorder caused by the union of autoantibodies and the components of the neuromuscular plaque, most frequently with the acetylcholine receptor.
Objective:
To assess the immediate surgical outcomes of extended thymectomy in patients with thymomatous and nonthymomatous myasthenia gravis.
Methods:
An observational, prospective and descriptive study was carried out to assess the immediate postoperative outcomes of 21 patients operated on for myasthenia gravis between June 2015 and May 2020. The variables studied were age, sex, associated thymic lesions, and immediate outcomes: complications and mortality that occurred up to thirty days after the intervention. The data were obtained from a Microsoft Access database.
Results:
Sixteen (76.2%) belonged to the female sex and five (23.8%) to the male sex. The highest number corresponded to MG with thymoma, followed by MG and thymic hyperplasia (8) and one with MG and thymic remains. Three patients (14.3%) were complicated. One had two complications: subcutaneous emphysema and septicemia; the next had unexplained fever; and the last one had superficial wound infection. There were no deaths.
Conclusions:
Extended transsternal thymectomy allows removal of the thymus and most of the adipose and aberrant thymic tissues in the neck and mediastinum. In patients treated by multidisciplinary teams, with experience in this surgery, outcomes regarding early complications and mortality are usually favorable.
REFERENCES
Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Ku HCh, Marx A, et al. Randomized trial of thymectomy in myasthenia grave. N Engl J Med. 2016;375(6):511-22.
Deenen JCW, Horlings CGC, Verschuuren JJGM, Verbeek ALM. The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J Neuromuscul Dis. 2015;2(1):73-85.
Lemaitre PhH, Keshavjee Sh. Uniportal video-Assisted Transcervical Thymectomy.Thorac Surg. Clin. 2019:29(2):187-94.
Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ. Treatment of Myasthenia Grave. Neurol Clin. 2018;36(2):311-37.
Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia grave: Executive summary. Neurology. 2016;87(4):419-25.
Chen KN, Xu SF, Gu ZD, Zhang W-M, Pan H, Su WZ, et al. Surgical treatment of complex malignant anterior mediastinal tumors invading the superior vena cava. World J Surg. 2006;30(2):162-70.
Pérez Nellar J, Pardo Núñez A, Martín González MA, de la Campa JD, Quiala Reyes M, Oliver Leal IR, et al. Miastenia grave en. Grupos Multidisciplinarios. Resultados obtenidos en la asistencia, docencia e investigaciones. En: Colectivo de autores. La Habana: Editorial Ciencias Médicas; 2008. p. 181-93.
Gilhus NE. Myasthenia grave. N Engl J Med. 2017;376(13):e25.
González R, Riquelme A, Fuenteaba M, González J, Fuentes A, Saldías R, et al. Miastenia grave: resultados inmediastos y alejados de la timectomía transesternal extendida. Rev Med Chile. 2018;146(4):460-9.
Suda T, Tochii D, Tochii S, Takagi Y. Trans-subxiphoid robotic thymectomy. Interact Cardiovasc Thorac Surg. 2015;20(5):669-71.
Suda T. Robotic subxiphoid thymectomy. J Vis Surg. 2016;2-118.
Suda T, Kaneda S, Hachimaru A, Tochii D, Maeda R, Tochii S, et al. Thymectomy via a subxiphoid approach: Single-port and robot-assisted. J Thorac Dis. 2016;8(suppl 3):S265-71.
Wei B, D'Amico TA. Thoracoscopic versus robotic approaches: advantages and disadvantages. Thorac Surg Clin. 2014;24(2):177-88.
Siwachat S, Tantraworasin A, Lapisatepun W, Ruengorn SH, Taioli E, Saeteng S, et al. Comparative clinical outcomes after thymectomy for myasthenia grave: Thoracoscopic versus transsternal approach. Asian Journal of Surgery. 2018;41(1):77-85.
Yang Y, Dong J, Huang Y. Thoracoscopic thymectomy versus open thymectomy for the treatment of thymoma: A meta-analysis. European Journal of Surgical Oncology (EJSO). 2016;42(22):1720-8.
Chang YW, Chou YC, Yeh CC, Hu CJ, Hung CJ, Lin CS, et al. Outcomes after major surgery in patients with myasthenia grave: A nationwide matched cohort study. PLoS One. 2017;12(6):e0180433.